Promega builds plant to produce regulated products

Published: 29-Aug-2011
Manufacturing Analysis

Including sample preparation systems and reagents

Promega Corporation, based in Madison, Wisconsin, US, has held a ground-breaking ceremony for a new cGMP facility to support business growth and customers who need FDA-regulated molecular biology products. These include sample preparation systems and reagents, which are part of diagnostic and medical tests sold by human diagnostic test providers.

The 260,000ft2 (24,150m2) facility will require an additional 100 people in the next five years. Most of the building will be dedicated to fixed and flexible manufacturing areas. It will also house a customer experience centre for training, laboratory demonstrations and conferences.

‘This building is our next step in expanding our product supply capabilities worldwide,’ said ceo Bill Linton.

Plans include a number of sustainable practices, including geothermal heating and cooling, dark sky compliant lighting, prairie restoration, bio-retention ponds for storm water run off among other sustainable features and construction practices.

Promega Corporation provides solutions and technical support to the life sciences industry. Its 2,000 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, molecular diagnostics and human identification.

See more

You may also like

Manufacturing

Promega opens new Shanghai facility

Read more
Provides additional r&d and cGMP manufacturing capabilities

Trending Articles

  1. Accelerating technology transfer in biopharmaceutical manufacturing This article explores how structured, digitally enabled and integrated technology transfer frameworks are accelerating the commercialisation of complex biopharmaceutical modalities by enhancing precision, speed and regulatory readiness
  2. ACG ACG is now the world’s largest integrated supplier and service provider to solid dosage manufacturers –providing hard shell capsules, barrier packaging solutions, track and trace systems, and process, packing and vision inspection equipment
  3. Eli Lilly to build a new $3bn facility to boost oral medicine manufacturing capacity in Europe The Netherlands site will bring 500 manufacturing and 1500 construction jobs while further strengthening Lilly's global supply chain
  4. Driving ADC innovation with complex chemistry solutions Abzena’s tailored chemistry expertise enables scalable, high-quality bioconjugate development from discovery to GMP production
  5. Aseptic spray drying: Transforming biotherapeutics for a new era With interest in aseptic spray drying on the rise in the pharmaceutical industry, Dr Kevin Robinson spoke to GEA’s David Costes about how the company is combining process, engineering and technological expertise with market insights to provide a safe, reliable and high-performance technology for advanced biotherapeutic powder applications

You may also like

Manufacturing

Promega opens new Shanghai facility

Provides additional r&d and cGMP manufacturing capabilities
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Toll processing: a strategic formula for smooth delivery in pharma

Challenged by raw material shortages, compliance demands and capacity limitations, pharmaceutical manufacturers can sometimes struggle to fulfil orders. Ben Beattie, Director of Forbeats, examines the benefits of partnering with a toll processor and the key factors to consider when selecting a provider
Manufacturing

Watson-Marlow to showcase advanced fluid path solutions at COMPAMED 2025

The fluid transfer solution specialist will highlight a variety of peristaltic pumps and associated fluid path technologies at this years COMPAMED 2025, taking place from 17-20 Nov in Düsseldorf, Germany
You need to be a subscriber to read this article.
Click here to find out more.
Personal Protection

Gas safety in smaller pharmaceutical facilities

Whether in the production process, for essential sterilisation or decontamination, the use of gases is fundamental in the pharmaceutical and biopharmaceutical industries. Each gas is, however, accompanied by risks and can pose significant hazards to the health of employees
Ingredients

Flowchem teaching manual now available to download

Guide offers step-by-step instructions for ten reactions including Nobel Prize-winning examples
Analysis

Efficient extraction of proteins from bacterial cells

SoluLyse from Amsbio is a bacterial protein extraction reagent that provides a highly efficient yet gentle method for extracting soluble proteins from bacterial cells
Manufacturing

Piramal Pharma reports Q2 and H1 FY26 results amid CDMO challenges

CDMO growth impacted by inventory destocking while consumer healthcare posts mid-teen growth
Subscribe now